These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21539436)

  • 1. Testosterone replacement therapy and cardiovascular risk factors modification.
    Chahla EJ; Hayek ME; Morley JE
    Aging Male; 2011 Jun; 14(2):83-90. PubMed ID: 21539436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone replacement, cardiovascular system and risk factors in the aging male.
    Vigna GB; Bergami E
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):69-74. PubMed ID: 16760629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone deficiency: a risk factor for cardiovascular disease?
    Jones TH
    Trends Endocrinol Metab; 2010 Aug; 21(8):496-503. PubMed ID: 20381374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with testosterone replacement in the elderly.
    Tenover JL
    Mayo Clin Proc; 2000 Jan; 75 Suppl():S77-81; discussion S82. PubMed ID: 10959222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.
    Tripathy D; Shah P; Lakshmy R; Reddy KS
    Horm Metab Res; 1998 Oct; 30(10):642-5. PubMed ID: 9851674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone deficiency: which patients should you screen and treat?
    Sadovsky R; Dhindsa S; Margo K
    J Fam Pract; 2007 May; 56(5 Suppl Testosterone):S1-20; quiz S21-3. PubMed ID: 17475159
    [No Abstract]   [Full Text] [Related]  

  • 8. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of testosterone-replacement therapy and recommendations for monitoring.
    Rhoden EL; Morgentaler A
    N Engl J Med; 2004 Jan; 350(5):482-92. PubMed ID: 14749457
    [No Abstract]   [Full Text] [Related]  

  • 10. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency.
    Miner MM; Khera M; Bhattacharya RK; Blick G; Kushner H
    Postgrad Med; 2011 May; 123(3):17-27. PubMed ID: 21566412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone, aging and quality of life.
    Morley JE; Haren MT; Kim MJ; Kevorkian R; Perry HM
    J Endocrinol Invest; 2005; 28(3 Suppl):76-80. PubMed ID: 16042363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone deficiency as a risk factor for cardiovascular disease.
    Ullah MI; Washington T; Kazi M; Tamanna S; Koch CA
    Horm Metab Res; 2011 Mar; 43(3):153-64. PubMed ID: 21283952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone and cardiovascular risk in men.
    Kelly DM; Jones TH
    Front Horm Res; 2014; 43():1-20. PubMed ID: 24943294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
    Turchi P; Simi S; Pescatori ES
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone therapy: treatment of metabolic disturbances in heart failure.
    Naghi JJ; Philip KJ; DiLibero D; Willix R; Schwarz ER
    J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):14-23. PubMed ID: 21097668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone and the aging male: to treat or not to treat?
    Bain J
    Maturitas; 2010 May; 66(1):16-22. PubMed ID: 20153946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Testosterone substitution in patients with hypogonadism].
    Martínez Portillo FJ; Cueva Martínez A; Martin Braun P; Fernández Arancibia MI; Jünemann KP; Alken P
    Arch Esp Urol; 2002 Sep; 55(7):827-38. PubMed ID: 12380312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone deficiency: myth, facts, and controversy.
    Miner M; Barkin J; Rosenberg MT
    Can J Urol; 2014 Jun; 21 Suppl 2():39-54. PubMed ID: 24978631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
    Guay AT; Traish A
    Urol Clin North Am; 2011 May; 38(2):175-83. PubMed ID: 21621084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone in men with hypogonadism and high cardiovascular risk, Pros.
    Rosano GM; Vitale C; Fini M
    Endocrine; 2015 Nov; 50(2):320-5. PubMed ID: 25749966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.